— Know what they know.
Not Investment Advice

REMI OTC

Remedent, Inc.
1W: +0.0% 1M: +14.3% 3M: +14.3% YTD: +33.3% 1Y: +300.0% 3Y: -99.5% 5Y: -99.4%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 63 · $15997 mcap · 13M float · 0.050% daily turnover · Short 98% of daily vol

Balance Sheet Trends

Total Assets
$5M -1.8% ▼
5Y CAGR: -7.0%
Total Liabilities
$3M +6.5% ▲
5Y CAGR: +4.6%
Shareholders Equity
$2M -11.9% ▼
5Y CAGR: -15.8%
Cash & Investments
$43K -58.9% ▼
5Y CAGR: -8.2%
Total Debt
$15K +0.0% ▲
5Y CAGR: -21.3%
Net Debt
-$43K +58.9% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$115K$78K$174K$105K$43K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$115K$78K$174K$105K$43K
Net Receivables$329K$386K$746K$722K$869K
Inventory$91K$102K$94K$93K$92K
Other Current Assets$0$8K$3K$2K$0
Total Current Assets$681K$575K$1M$922K$1M
Property, Plant & Equip.$67K$68K$68K$41K$21K
Goodwill & Intangibles$0$58K$37K$21K$0
Long-Term Investments$7M$7M$6M$5M$4M
Other Non-Current Assets$0-$60K-$39K-$21K$0
Total Non-Current Assets$7M$7M$6M$5M$4M
Total Assets$8M$7M$7M$6M$5M
— Liabilities —
Accounts Payable$2M$2M$2M$1M$2M
Short-Term Debt-$502K$5K$0$0$15K
Deferred Revenue$101K$111K$110K$168K$144K
Other Current Liabilities$487K$274K$1M$1M$228K
Total Current Liabilities$3M$3M$3M$3M$3M
Long-Term Debt$5K$0$0$0$0
Other Non-Current Liab.$0$6K$16K$0$0
Total Non-Current Liabilities$5K$6K$16K$0$0
Total Liabilities$3M$3M$3M$3M$3M
— Equity —
Common Stock$20K$20K$20K$20K$20K
Retained Earnings-$19M-$19M-$19M-$20M-$21M
Accumulated OCI-$1M-$1M-$987K-$1M-$1M
Total Stockholders Equity$5M$4M$4M$3M$2M
Total Liabilities & Equity$8M$7M$7M$6M$5M
— Key Metrics —
Total Debt$5K$5K$0$0$15K
Net Debt-$109K-$72K-$174K-$105K-$43K
Total Investments$7M$7M$6M$5M$4M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms